Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 3
2010 1
2011 3
2012 2
2013 1
2014 2
2015 3
2016 1
2017 1
2018 2
2019 1
2020 1
2021 4
2022 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
A modular platform for targeted RNAi therapeutics.
Kedmi R, Veiga N, Ramishetti S, Goldsmith M, Rosenblum D, Dammes N, Hazan-Halevy I, Nahary L, Leviatan-Ben-Arye S, Harlev M, Behlke M, Benhar I, Lieberman J, Peer D. Kedmi R, et al. Among authors: goldsmith m. Nat Nanotechnol. 2018 Mar;13(3):214-219. doi: 10.1038/s41565-017-0043-5. Epub 2018 Jan 29. Nat Nanotechnol. 2018. PMID: 29379205
A Combinatorial Library of Lipid Nanoparticles for Cell Type-Specific mRNA Delivery.
Naidu GS, Yong SB, Ramishetti S, Rampado R, Sharma P, Ezra A, Goldsmith M, Hazan-Halevy I, Chatterjee S, Aitha A, Peer D. Naidu GS, et al. Among authors: goldsmith m. Adv Sci (Weinh). 2023 Jul;10(19):e2301929. doi: 10.1002/advs.202301929. Epub 2023 Apr 24. Adv Sci (Weinh). 2023. PMID: 37092557 Free PMC article.
Delivery of Therapeutic RNA to the Bone Marrow in Multiple Myeloma Using CD38-Targeted Lipid Nanoparticles.
Tarab-Ravski D, Hazan-Halevy I, Goldsmith M, Stotsky-Oterin L, Breier D, Naidu GS, Aitha A, Diesendruck Y, Ng BD, Barsheshet H, Berger T, Vaxman I, Raanani P, Peer D. Tarab-Ravski D, et al. Among authors: goldsmith m. Adv Sci (Weinh). 2023 Jul;10(21):e2301377. doi: 10.1002/advs.202301377. Epub 2023 May 12. Adv Sci (Weinh). 2023. PMID: 37171801 Free PMC article.
Dual-Targeted Lipid Nanotherapeutic Boost for Chemo-Immunotherapy of Cancer.
Yong SB, Ramishetti S, Goldsmith M, Diesendruck Y, Hazan-Halevy I, Chatterjee S, Somu Naidu G, Ezra A, Peer D. Yong SB, et al. Among authors: goldsmith m. Adv Mater. 2022 Apr;34(13):e2106350. doi: 10.1002/adma.202106350. Epub 2022 Feb 10. Adv Mater. 2022. PMID: 35044699
Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics.
Dammes N, Goldsmith M, Ramishetti S, Dearling JLJ, Veiga N, Packard AB, Peer D. Dammes N, et al. Among authors: goldsmith m. Nat Nanotechnol. 2021 Sep;16(9):1030-1038. doi: 10.1038/s41565-021-00928-x. Epub 2021 Jun 17. Nat Nanotechnol. 2021. PMID: 34140675 Free PMC article.
Nanoparticle hydrophobicity dictates immune response.
Moyano DF, Goldsmith M, Solfiell DJ, Landesman-Milo D, Miranda OR, Peer D, Rotello VM. Moyano DF, et al. Among authors: goldsmith m. J Am Chem Soc. 2012 Mar 7;134(9):3965-7. doi: 10.1021/ja2108905. Epub 2012 Feb 24. J Am Chem Soc. 2012. PMID: 22339432 Free PMC article.
27 results